A study investigating the effect on testosterone suppression and prostate specific antigen (PSA) levels in patients with metastatic prostate cancer after switching from GnRH agonists to degarelix
Latest Information Update: 01 Sep 2015
At a glance
- Drugs Degarelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
Most Recent Events
- 01 Sep 2015 New trial record